Marcel Behr
![Marcel Behr Marcel Behr](/epi-biostat-occh/files/epi-biostat-occh/styles/medium_focal__220_x_220_/public/spr_7979fe.jpg?itok=waXrr8Bj)
Dr. Behr is a clinician-scientist with appointments of Full Professor in the Department of Medicine and Associate member in the departments of Epidemiology and Biostatistics as well as Microbiology and Immunology. He is the founding Director of the º«¹úÂãÎè International TB Centre and led it from 2012 to 2018. He is the Associate Program Leader of the Infectious Diseases and Immunity in Global Health Program at the Research Institute of the º«¹úÂãÎè Health Centre since 2016 and in 2017 he became the co-Director the º«¹úÂãÎè Interdisciplinary Initiative in Infection and Immunity (º«¹úÂãÎè-i4). He is the interim director of º«¹úÂãÎè Infectious Diseases Division.
Dr. Behr trained at the University of Toronto, Queen’s, º«¹úÂãÎè and Stanford. His work has been recognized in Quebec (Chercheur National Award of the FRSQ), Canada (Joe Doupe Award of the Clinical Society for Clinical Investigation, Fellow of the Canadian Academy of Health Sciences and of the Royal Society of Canada) and beyond (Election to the American Society for Clinical Investigation and Fellow of the American Academy of Microbiology).  Dr. Behr’s lab uses bacterial genetics to study the epidemiology and pathogenesis of mycobacterial diseases.Â
Webpage
Lab websiteÌý´¥Ìýº«¹úÂãÎè International TB Centre
Applying the techniques of molecular biology to the study of infectious diseases epidemiology. Using genome sequencing, we study the molecular epidemiology of tuberculosis and non-tuberculous mycobacteria. As well, other ongoing work involves the use of genomic methodologies to study the pathogenesis of mycobacterial infections.